© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion
Cardiothoracic Research Laboratory, The Carlyle Fraser Heart Center/Crawford Long Hospital, Emory University School of Medicine, 550 Peachtree Street NE, Atlanta, GA 30308-2225, USA
zzhao{at}emory.edu
* Corresponding author. Tel.: +1-404-686-2511; fax: +1-404-686-4888.
Objective: Myocardial apoptosis is primarily triggered during reperfusion (R) through various mechanisms that may involve endonuclease to cleavage genomic DNA in the internucleosomal linker regions. However, the relative contribution of myocardial apoptosis to development of myocardial injury during R remains unknown. In the present study, we examined whether inhibition of apoptosis with aurintricarboxylic acid (ATA), an endonuclease inhibitor, during R reduces infarct size and improves regional contractile function. Methods and Results: In two groups of chronically-instrumented dogs, 1 h of left anterior descending (LAD) coronary occlusion was followed by 24 h of R with infusion of saline (control, n = 8) or ATA (1 mg/kg/h, n = 8) into the left atrium starting 5 min before R and continuing for 2 h. ATA significantly reduced apoptotic cells (TUNEL staining) in the peri-necrotic myocardium (12±1%* vs. 36±4%), consistent with the absence of DNA laddering. To confirm inhibition of apoptosis with ATA, densitometrically, Bcl-2 (% of normal myocardium) was significantly increased vs. control (102±12* vs. 68±9) and Bax as well as the activated caspase-3 were significantly reduced vs. control (108±17* vs. 194±42 and –29±4* vs. 174±43, respectively). ATA significantly improved segmental shortening (3.3±1.2* vs. –1.8±0.7%) and segmental work (79.3±11.3* vs. 7.1±5.8 mmHg/mm) in area at risk myocardium, and reduced infarct size (TTC staining, 27±0.2* vs. 37±0.5%), confirmed by lower plasma creatine kinase activity. In addition, myocardial blood flow (0.9±0.1* vs. 0.4±0.1 ml/min/g) and endothelial-dependent maximal vascular relaxation (119±6* vs. 49±8%) were significantly improved. Myeloperoxidase activity in area at risk myocardium, a marker for neutrophil accumulation, was also significantly reduced (17±4* vs. 138±28 
Abs/min). Conclusions: These data suggest that the inhibition of apoptosis during R is associated with a reduction in infarction, improvement in regional contractile and vascular endothelial functions as well as augmentation in myocardial blood flow. *P<0.05 vs. control group.
KEYWORDS Apoptosis; Infarct size; Myocardial contraction; Reperfusion
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Q. Sun, Z. Kang, J. Cai, W. Liu, Y. Liu, J. H. Zhang, P. J. Denoble, H. Tao, and X. Sun Hydrogen-Rich Saline Protects Myocardium Against Ischemia/Reperfusion Injury in Rats Experimental Biology and Medicine, October 1, 2009; 234(10): 1212 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Bucciarelli, R. Ananthakrishnan, Y. C. Hwang, M. Kaneko, F. Song, D. R. Sell, C. Strauch, V. M. Monnier, S. F. Yan, A. M. Schmidt, et al. RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium Diabetes, July 1, 2008; 57(7): 1941 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aleshin, R. Ananthakrishnan, Q. Li, R. Rosario, Y. Lu, W. Qu, F. Song, S. Bakr, M. Szabolcs, V. D'Agati, et al. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1823 - H1832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dyugovskaya, A. Polyakov, P. Lavie, and L. Lavie Delayed Neutrophil Apoptosis in Patients with Sleep Apnea Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 544 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Yellon and D. J. Hausenloy Myocardial Reperfusion Injury N. Engl. J. Med., September 13, 2007; 357(11): 1121 - 1135. [Full Text] [PDF]
|
|
|
|
|
|
M. Das Apoptosis as a therapeutic target in heart failure Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1322 - H1323. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ma, H.-F. Zhang, L. Yu, Q.-J. Zhang, J. Li, J.-H. Huo, X. Li, W.-Y. Guo, H.-C. Wang, and F. Gao Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: Role of Akt-stimulated NO production Cardiovasc Res, January 1, 2006; 69(1): 57 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P.M. van Empel, A. T.A. Bertrand, L. Hofstra, H. J. Crijns, P. A. Doevendans, and L. J. De Windt Myocyte apoptosis in heart failure Cardiovasc Res, July 1, 2005; 67(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Juhaszova, C. Rabuel, D. B. Zorov, E. G. Lakatta, and S. J. Sollott Protection in the aged heart: preventing the heart-break of old age? Cardiovasc Res, May 1, 2005; 66(2): 233 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. McCully, H. Wakiyama, Y.-J. Hsieh, M. Jones, and S. Levitsky Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1923 - H1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Anselmi, A. Abbate, F. Girola, G. Nasso, G. G.L. Biondi-Zoccai, G. Possati, and M. Gaudino Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 304 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Hausenloy and D. M Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res, February 15, 2004; 61(3): 448 - 460. [Abstract] [Full Text] [PDF]
|
|